| Application no. and date | 08794174.6 (espacenet) (Federated) (European Patent Register), 20080822 | | Patent/reg. no. and date | DK/EP 2200616, 20121226 | | Publication date | 20100630 | | Priority no. and date | US 957523 P, 20070823, US 957525 P, 20070823 | | EP pub. no. and date |
EP 2200616 20100630 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST 102938 | | Inventor | POEWE, Werner, Medical University Of Innsbruck
Department of Neurology
Anichstrasse 35
A-6020 Innsbruck, AT,
ERIKSSON, HÃ¥kan, AstraZeneca R&D Södertälje
S-151 85 Södertälje, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 31/522 (2006.01) , A61P 25/28 (2006.01) | | Title | Mipo-hæmmere til behandling huntingtons sygdom og multipel system atrofi | | Int. application no. | SE2008050950 | | Int. publication no. | WO2009025618 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
